Literature DB >> 15638768

Defensins--non-antibiotic use for vaccine development.

Arya Biragyn1.   

Abstract

Vaccines should elicit protective and long lasting immune memory, which depends on well choreographed responses between innate and acquired immunity. Defensins are small host defense peptides of innate immunity hitherto reported to have antimicrobial activity, which also orchestrate chemotaxis and activation of effector immune cells, including immature dendritic cells. This review analyzes the biological meaning of the immunomodulatory and immunoenhancing features of defensins and their use for the development of novel vaccines to combat cancer and clinically relevant diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638768     DOI: 10.2174/1389203053027601

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  9 in total

Review 1.  Defensins as anti-inflammatory compounds and mucosal adjuvants.

Authors:  Karl G Kohlgraf; Lindsey C Pingel; Deborah E Dietrich; Kim A Brogden
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

2.  Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2.

Authors:  Arya Biragyn; Marta Coscia; Kunio Nagashima; Michael Sanford; Howard A Young; Purevdorj Olkhanud
Journal:  J Leukoc Biol       Date:  2008-01-11       Impact factor: 4.962

3.  Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins.

Authors:  Robert I Lehrer; Grace Jung; Piotr Ruchala; Wei Wang; Ewa D Micewicz; Alan J Waring; Eugene J Gillespie; Kenneth A Bradley; Adam J Ratner; Richard F Rest; Wuyuan Lu
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

4.  High-throughput sequence analysis of turbot (Scophthalmus maximus) transcriptome using 454-pyrosequencing for the discovery of antiviral immune genes.

Authors:  Patricia Pereiro; Pablo Balseiro; Alejandro Romero; Sonia Dios; Gabriel Forn-Cuni; Berta Fuste; Josep V Planas; Sergi Beltran; Beatriz Novoa; Antonio Figueras
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 5.  Oncolytic activities of host defense peptides.

Authors:  Sammy Al-Benna; Yechiel Shai; Frank Jacobsen; Lars Steinstraesser
Journal:  Int J Mol Sci       Date:  2011-11-16       Impact factor: 5.923

6.  The Effect of Nonsurgical Periodontal Therapy on HNP1-3 Level in Gingival Crevicular Fluid of Chronic Periodontitis Patients.

Authors:  Ewa Dolińska; Anna Skurska; Małgorzata Pietruska; Violetta Dymicka-Piekarska; Robert Milewski; Jan Pietruski; Anton Sculean
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-02-15       Impact factor: 4.291

Review 7.  Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic.

Authors:  Waqas Ali; Ahmad Elsahn; Darren S J Ting; Harminder S Dua; Imran Mohammed
Journal:  Antibiotics (Basel)       Date:  2022-04-01

8.  Short toxin-like proteins abound in Cnidaria genomes.

Authors:  Yitshak Tirosh; Itai Linial; Manor Askenazi; Michal Linial
Journal:  Toxins (Basel)       Date:  2012-11-16       Impact factor: 4.546

9.  ProHNPs are specific markers of normal myelopoiesis.

Authors:  F Emmertsen; A Glenthøj; J Sønderskov; P Kampmann; H Sengeløv; N Borregaard
Journal:  Blood Cancer J       Date:  2014-03-21       Impact factor: 11.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.